Cargando…
Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response
Autologous cancer cell vaccines represent a multivalent patient-specific treatment. Studies have demonstrated that these immunotherapies should be combined with immunomodulators to improve results. We tested in breast cancer the antitumor effects of a 200 µg autologous tumor cells homogenate combine...
Autores principales: | Godoy-Calderón, María José, Salazar, Víctor, González-Marcano, Eglys, Convit, Ana Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945537/ https://www.ncbi.nlm.nih.gov/pubmed/29755647 http://dx.doi.org/10.18632/oncotarget.25044 |
Ejemplares similares
-
Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy
por: Convit, J., et al.
Publicado: (2015) -
Erratum to: Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy
por: Convit, J., et al.
Publicado: (2016) -
Unraveling the Mechanism of the Antitumor Activity of Bacillus Calmette-Guérin
por: Li, Roger, et al.
Publicado: (2020) -
Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment
por: Godoy-Calderón, María José, et al.
Publicado: (2019) -
Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
por: Parmar, Kanak, et al.
Publicado: (2021)